Literature DB >> 1356098

Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

M A Degli-Esposti1, L J Abraham, V McCann, T Spies, F T Christiansen, R L Dawkins.   

Abstract

The major histocompatibility complex (MHC) contains multiple and diverse genes which may be relevant to the induction and regulation of autoimmune responses in insulin dependent diabetes mellitus (IDDM). In addition to HLA class I and II, the possible candidates include TNF, C4, and several other poorly defined polymorphic genes in the central MHC region. This study describes two approaches which take advantage of the fact that the relevant genes are carried by highly conserved ancestral haplotypes such as 8.1 (HLA-B8, TNFS, C4AQ0, C4B1, DR3, DQ2). First, three "diabetogenic" haplotypes (two Caucasoid and one Mongoloid) have been compared and it has been shown that all three share a rare allele of BAT3 as well as sharing DR3, DQ2. In 43 sequential patients with IDDM the cross product ratio for BAT3S was 4.8 (p less than 0.01) and 6.9 for HLA-B8 plus BAT3S (p less than 0.001). Second, partial or recombinant ancestral haplotypes with either HLA class I (HLA-B8) or II (HLA-DR3, DQ2) alleles were identified. Third, using haplotypic polymorphisms such as the one in BAT3, we have shown that all the patients carrying recombinants of the 8.1 ancestral haplotype share the central region adjacent to HLA-B. These findings suggest that both HLA and non-HLA genes are involved in conferring susceptibility to IDDM, and that the region between HLA-B and BAT3 contains some of the relevant genes. By contrast, similar approaches suggest that protective genes map to the HLA class II region.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356098     DOI: 10.1007/bf00218041

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  35 in total

1.  Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes.

Authors:  L J Abraham; C Leelayuwat; G Grimsley; M A Degli-Esposti; A Mann; W J Zhang; F T Christiansen; R L Dawkins
Journal:  Tissue Antigens       Date:  1992-03

2.  Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B.

Authors:  T Spies; M Bresnahan; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Haplotypic polymorphisms of the TNFB gene.

Authors:  L J Abraham; D C Du; K Zahedi; R L Dawkins; A S Whitehead
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain.

Authors:  J Banerji; J Sands; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Distribution of HLA A, B and C antigens in an Australian population.

Authors:  B R Hawkins; J B Houliston; R L Dawkins
Journal:  Hum Genet       Date:  1979-11       Impact factor: 4.132

Review 7.  The interaction between protein-derived immunogenic peptides and Ia.

Authors:  S Buus; A Sette; H M Grey
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

8.  Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains.

Authors:  Y Fujishima; Y Koide; T Kaidoh; M Nishimura; T O Yoshida
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

9.  Major histocompatibility complex-linked diabetogenic gene of the nonobese diabetic mouse. Analysis of genomic DNA amplified by the polymerase chain reaction.

Authors:  H Ikegami; G S Eisenbarth; M Hattori
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

10.  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.

Authors:  H Kelly; V J McCann; P H Kay; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

View more
  32 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease.

Authors:  B Marshall; C Leelayuwat; L J Abraham; M Pinelli; R L Dawkins
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease.

Authors:  N Mizuki; M Ota; M Kimura; S Ohno; H Ando; Y Katsuyama; M Yamazaki; K Watanabe; K Goto; S Nakamura; S Bahram; H Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locus.

Authors:  S J Greenberg; K Fujihara; S M Selkirk; F Yu; T L Du; N Glenister; P Hohmann; M H Rickert; P O Spence; C E Miller; L D Jacobs
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

5.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C.

Authors:  R P Nair; P Stuart; T Henseler; S Jenisch; N V Chia; E Westphal; N J Schork; J Kim; H W Lim; E Christophers; J J Voorhees; J T Elder
Journal:  Am J Hum Genet       Date:  2000-05-05       Impact factor: 11.025

Review 6.  Genetics of inflammatory bowel disease: the role of the HLA complex.

Authors:  Tariq Ahmad; Sara-E Marshall; Derek Jewell
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.

Authors:  Vidya S Limaye; Sue Lester; Peter Bardy; Philip Thompson; Sally Cox; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

8.  Cloning and genomic characterization of LST1: a new gene in the human TNF region.

Authors:  I Holzinger; A de Baey; G Messer; G Kick; H Zwierzina; E H Weiss
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complex.

Authors:  G Morahan; M Mehta; E McKinnon; I James
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

10.  Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.

Authors:  Roberta Pastorino; Cristina Menni; Monserrata Barca; Luisa Foco; Valeria Saddi; Giovanna Gazzaniga; Raffaela Ferrai; Luca Mascaretti; Frank Dudbridge; Carlo Berzuini; Salvatore Bruno Murgia; Maria Luisa Piras; Anna Ticca; Pier Paolo Bitti; Luisa Bernardinelli
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.